, Novo Nordisk Pharmaceuticals (Phils.), Inc. Bonifacio Global City, Taguig, Philippines

• Journal of the ASEAN Federation of Endocrine Societies Vol. 33 No. 2 (2018): November Issue - Original Articles
  The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes
  Abstract  Abstract  HTML  PDF